Education
About Us
Working with TipRanks
Follow Us
Sabra Healthcare REIT (SBRA)
NASDAQ:SBRA
SBRA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.31 - $20.03
Previous CloseN/A
Volume723.92K
Average Volume (3M)2.71M
Market Cap
$4.11B
Enterprise Value$6.84B
Total Cash (Recent Filing)$60.47M
Total Debt (Recent Filing)$1.76B
Price to Earnings (P/E)32.2
Beta0.70
Next Earnings
Apr 30, 2025EPS Estimate
0.17Last Dividend Ex-Date
Feb 14, 2025Dividend Yield6.95%
Share Statistics
EPS (TTM)0.54
Shares Outstanding237,910,980
10 Day Avg. Volume2,833,545
30 Day Avg. Volume2,714,751
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)N/A
Price to Sales (P/S)5.84
Price to Cash Flow (P/CF)12.80
P/FCF Ratio9.50
Enterprise Value/Market Cap1.67
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit14.37
Enterprise Value/Ebitda15.97
Forecast
1Y Price Target
$19.43Price Target Upside11.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
---
Sabra Healthcare REIT News
PremiumCompany Announcements
Sabra Healthcare Reit Projects Positive 2025 Amid Growth
PremiumCompany Announcements
Sabra Healthcare REIT Reports Strong Q4 2024 Results
PremiumCompany Announcements
Sabra Healthcare REIT Reports Strong Q4 2024 Results
---
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationsAnalyst upgrades shares of Sabra Healthcare REIT to Market Outperform, expecting multiple tailwinds to result in outsized returns.
Debt ManagementNet debt to adjusted EBITDA has improved to 5.3x versus 5.7x one year ago.
Portfolio PerformanceThe skilled nursing portfolio is carrying an EBITDARM coverage ratio above 2x, while same-store SHOP assets are producing high-teens NOI growth.
Bears Say
Asset DispositionsUnexpected dispositions amounting to $56.5M in the fourth quarter.
Financial GuidanceManagement's guidance is for Core FFO to be within a range of $1.43-$1.46 per share ($1.445 midpoint), slightly below consensus of $1.48 per share.
Investment ActivityNo new investments announced, which may be a disappointment compared to peers.
---
Ownership Overview
1.81% Insiders
24.11% Mutual Funds
12.13% Other Institutional Investors
28.53% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SBRA FAQ
What was Sabra Healthcare REIT’s price range in the past 12 months?
Sabra Healthcare REIT lowest stock price was $13.30 and its highest was $20.03 in the past 12 months.
What is Sabra Healthcare REIT’s market cap?
Sabra Healthcare REIT’s market cap is $4.11B.
When is Sabra Healthcare REIT’s upcoming earnings report date?
Sabra Healthcare REIT’s upcoming earnings report date is Apr 30, 2025 which is in 36 days.
How were Sabra Healthcare REIT’s earnings last quarter?
Sabra Healthcare REIT released its earnings results on Feb 19, 2025. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.163 by $0.027.
Is Sabra Healthcare REIT overvalued?
According to Wall Street analysts Sabra Healthcare REIT’s price is currently Undervalued.
Does Sabra Healthcare REIT pay dividends?
Sabra Healthcare REIT pays a Quarterly dividend of $1.2 which represents an annual dividend yield of 6.95%. See more information on Sabra Healthcare REIT dividends here
What is Sabra Healthcare REIT’s EPS estimate?
Sabra Healthcare REIT’s EPS estimate is 0.17.
How many shares outstanding does Sabra Healthcare REIT have?
Sabra Healthcare REIT has 237,910,980 shares outstanding.
What happened to Sabra Healthcare REIT’s price movement after its last earnings report?
Sabra Healthcare REIT reported an EPS of $0.19 in its last earnings report, beating expectations of $0.163. Following the earnings report the stock price went down -0.967%.
Which hedge fund is a major shareholder of Sabra Healthcare REIT?
Currently, no hedge funds are holding shares in SBRA
---
Sabra Healthcare REIT Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$19.43 (11.99% Upside)
$19.43 (11.99% Upside)
Blogger Sentiment
Bullish
SBRA Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 74.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $40.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.82%
12-Months-Change
Fundamentals
Return on Equity
4.57%
Trailing 12-Months
Asset Growth
-1.53%
Trailing 12-Months
Company Description
Sabra Healthcare REIT
Sabra Healthcare REIT, Inc. (SBRA) is a real estate investment trust that specializes in acquiring, owning, and leasing healthcare-related real estate properties. The company's portfolio primarily includes skilled nursing facilities, senior housing communities, and specialty hospitals across the United States and Canada. Its investments are aimed at fostering a diversified portfolio that supports the healthcare sector's infrastructure needs.
---
SBRA Company Deck
---
SBRA Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong performance in Sabra's senior housing and skilled portfolios, with record high EBITDARM coverage and significant growth in managed senior housing. However, challenges remain with workforce availability and political risks related to potential Medicaid cuts. Despite these concerns, Sabra's financial growth and strong balance sheet provide a positive outlook for 2025.Read More>---
SBRA Stock 12 Month Forecast
Average Price Target
$19.43
▲(11.99% Upside)
Technical Analysis
Best Analysts Covering SBRA
1 Year
1 Year Success Rate
5/8 ratings generated profit
1 Year Average Return
+20.04%
reiterated a buy rating 8 months ago
Copying Omotayo Okusanya's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +20.04% per trade.
---